Brief: Puma Biotechnology To Present Neratinib Data At The San Antonio Breast Cancer Symposium (SABCS)
19/11/2021 14:15
Nov 19 (Reuters) - Puma Biotechnology Inc PBYI.O :
* PUMA BIOTECHNOLOGY TO PRESENT NERATINIB DATA AT THE SAN
ANTONIO
BREAST CANCER SYMPOSIUM (SABCS)
Source text for Eikon: ID:nBw9yk7HSa
Further company coverage: PBYI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Puma Biotechnology
See all newsBrief: Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(C)(4)
Brief: Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Puma Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Corrected: Puma Biotechnology lifts 2026 outlook as Q2 revenue rises on NERLYNX demand
Brief: Puma Biotechnology Q2 Adjusted EPS USD 0.2